![](https://d3ilqtpdwi981i.cloudfront.net/5dpKCJ3vw1l7os9VXCT6RrulZWY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/f1/69/a1/f169a1a3-9f06-4829-9d6c-d8f93e8ebf34/file.jpg)
Article
Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma
International Journal of Hematology
(2019)
Disciplines
Publication Date
May 1, 2019
DOI
10.1007/s12185-019-02592-3
Citation Information
Jose D. Sandoval-Sus, Amanda Brahim, Alina Khan, Barbara Raphael, et al.. "Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma" International Journal of Hematology Vol. 109 Iss. 5 (2019) p. 622 - 626 Available at: http://works.bepress.com/marco-ruiz/2/